Navigation Links
Mytrus Electronic Informed Consent System Selected for 2013 Product Leadership Award in Clinical Trials
Date:8/26/2013

SAN FRANCISCO, CA (PRWEB) August 26, 2013

Mytrus Inc. announced today that they have been awarded Frost & Sullivan’s prestigious clinical trials product leadership award for their pioneering electronic informed consent application, enroll™.

Frost & Sullivan, a respected global research organization that tracks more than 250,000 companies, compared Mytrus to other market competitors in a rigorous review that touched on several elements of product design, adoption, ease of use and market potential. At the end of the review, Mytrus was named winner of the North American Product Leadership Award in Clinical Trials for 2013.

“Mytrus has developed a product that makes the cumbersome, but critical process of informed consent simple and efficient for patients and offers sponsors and regulators new opportunities to collect and track important informed consent data analytics,” said Prakhar Verma, Industry Analyst at Frost & Sullivan. “Like other truly disruptive innovations, enroll™ is simple yet powerful and defines a new market for collecting clinical trial consent electronically on all research studies.”

Informed consent forms typically run 8 to 50 pages of often-complex legal and medical information. Participants frequently fail to read or understand the documents before they consent to participating in a trial. Further, there are no requirements for assessing participants’ understanding of the protocol or risks.

“Informed consent is one of the most important, but often neglected, elements of enrolling patients in clinical trials” said Mytrus CEO Anthony Costello. “We are humbled to receive this award for our work in the area of eConsent and we are encouraged to see the number of companies rushing to adopt more patient-centered tools for clinical research.”

According to ClinicalTrials.gov, there were more than 60,000 registered clinical trials ongoing in the United States last June and the number is growing. Studies are often long and complex. The time and effort spent recruiting patients can represent a third of the cost of trials, yet once enrolled in a trial, patients often drop out due to poor understanding of the treatment protocol. All of this contributes, in the end, to higher drug development costs.

A study published earlier this year in the Public Library of Science also showed that patients and investigators receiving information electronically via Mytrus on iPads had far greater comprehension and retention of the material than those receiving the same information on paper.

Earlier this year, inVentiv Health took an equity position in Mytrus, Inc., a pioneer in “virtual clinical trials” and electronic informed consent, as part of a suite of services and technologies inVentiv has assembled to dramatically improve trial efficiency. Mytrus has also partnered with the WIRB-Copernicus Group, the world’s largest provider of regulatory and ethical review services for human research, to deliver enroll™ to customers using the WIRB-Copernicus Group for study ethics review and approval.

Mytrus will accept its award at a gala dinner sponsored by Frost & Sullivan in San Jose, CA on September 11th.

About Mytrus
Founded in 2009, Mytrus is a California-based clinical technology and services company built on the idea that modern technologies can enable people to safely and effectively participate in clinical trials without requiring them to live near a study center. The company’s proprietary methods can dramatically improve patient recruitment timelines, increase patient retention and reduce overall study costs for sponsors. Learn more about Mytrus at http://www.mytrus.com or find the company on Facebook and Twitter @mytrus.

Read the full story at http://www.prweb.com/releases/informed-consent/mytrus/prweb11057997.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Researching graphene nanoelectronics for a post-silicon world
2. UCSB professor receives award for graphene electronics research
3. Researchers develop one of the worlds smallest electronic circuits
4. New path to flex and stretch electronics
5. Nanowiggles: Scientists discover graphene nanomaterials with tunable functionality in electronics
6. Smaller and more powerful electronics requires the understanding of quantum jamming physics
7. Keeping electronics cool
8. Graphene electronics moves into a third dimension
9. Johns Hopkins Health System is 100th healthcare Provider to Integrate OnBase With Leading Electronic Medical Record System
10. A step toward better electronics
11. Functional oxide thin films create new field of oxide electronics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... CAMBRIDGE, Mass. , March 22, 2017   ... of next-generation cancer therapeutics designed to target cancer stemness ... Patricia S. Andrews as Chief Executive Officer, ... will succeed Chiang J. Li , M.D., FACP, ... company ten years ago. Under his leadership, Boston Biomedical ...
(Date:3/22/2017)... ... March 21, 2017 , ... Okyanos Cell Therapy has announced ... of their live events series, “Stem Cell Therapy: The Next Phase in the Evolution ... 2013 Stem Cell Research and Therapy Act, Okyanos maintains a mission to ...
(Date:3/22/2017)... ... March 21, 2017 , ... Aqua Design Innovations ... goal and raising over $30,000 in the first 40 minutes of crowdfunding. EcoQube ... herbs fast, easy, and affordably, anywhere. , “Simply add fertilized water and in ...
(Date:3/22/2017)... ... March 21, 2017 , ... Functional near-infrared spectroscopy (fNIRS), an optical imaging tool ... way to track the brain’s response to acute pain in adults and infants. , ... ,” published today in the journal Neurophotonics , by SPIE, the international ...
Breaking Biology Technology:
(Date:3/2/2017)... Summary This report provides all the ... interests and activities since 2010. ... Read the full report: http://www.reportlinker.com/p03605615-summary/view-report.html ... report provides an in-depth insight into the partnering activity of ... On demand company reports are prepared upon purchase to ensure ...
(Date:3/2/2017)... Australia , March 2, 2017 Australian ... Ltd (ASX: CYP), has signed an agreement with ... from the Monash Biomedicine Discovery Institute and Department of ... to conduct a further preclinical study to support the ... treatment of asthma.  Asthma is a ...
(Date:2/28/2017)... -- News solutions for biometrics, bag drop and New ... At ... 16 March, Materna will present its complete end-to-end passenger journey, ... a real benefit for passengers. To accelerate the whole passenger ... point solutions to take passengers through the complete integrated process ...
Breaking Biology News(10 mins):